Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme

Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University Faculty of Medicine, Fukuoka, Japan.

OBJECTIVES: The present study aimed to determine the role of nitric oxide (NO) and angiotensin-converting enzyme (ACE) in bradykinin (BK)-induced dilation of human coronary arteries in vivo. BACKGROUND: BK, produced by way of the kinin-kallikrein system, causes endothelium-dependent vasodilation. However, little is known about the mechanism of BK-induced dilation of coronary arteries in humans in vivo. METHODS: The effects of an inhibitor of NO synthesis and of an ACE inhibitor on BK-induced coronary vasodilation were examined in 20 patients who had no significant atherosclerotic stenosis in the artery under study. Lumen diameters of the large epicardial coronary arteries and coronary blood flow (CBF) were measured by quantitative coronary arteriography and intracoronary Doppler technique. RESULTS: Intracoronary infusion of BK (0.6 and 2.0 micrograms/min) increased coronary artery diameter and CBF with no change in arterial pressure or heart rate. The BK-induced increases in coronary artery diameter and CBF were significantly reduced (p < 0.01) after pretreatment with NG-monomethyl-L-arginine (200 mumol) and were significantly increased (p < 0.01) after pretreatment with enalaprilat (50 micrograms). CONCLUSIONS: BK-induced dilation of human large epicardial and resistance coronary arteries is mediated by NO and increased by prior ACE inhibition.

This article has been cited by other articles:

				T. Fulop, E. Jebelovszki, N. Erdei, T. Szerafin, T. Forster, I. Edes, A. Koller, and Z. Bagi Adaptation of Vasomotor Function of Human Coronary Arterioles to the Simultaneous Presence of Obesity and Hypertension Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2348 - 2354. [Abstract] [Full Text] [PDF]

				N. L.M. Cruden, K. A.A. Fox, C. A. Ludlam, N. R. Johnston, and D. E. Newby Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition Hypertension, December 1, 2004; 44(6): 913 - 918. [Abstract] [Full Text] [PDF]

				N. L.M. Cruden, F. N. Witherow, D. J. Webb, K. A.A. Fox, and D. E. Newby Bradykinin Contributes to the Systemic Hemodynamic Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1043 - 1048. [Abstract] [Full Text] [PDF]

				R. Komers, R. Simkova, L. Kazdova, J. Ruzickova, and T. Pelikanova Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 33 - 38. [Abstract] [PDF]

				T. Matsumoto, K. Minai, H. Horie, N. Ohira, H. Takashima, Y. Tarutani, Y. o Yasuda, T. Ozawa, S. Matsuo, M. Kinoshita, et al. Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1373 - 1379. [Abstract] [Full Text] [PDF]

				F. N. Witherow, A. Helmy, D. J. Webb, K. A.A. Fox, and D. E. Newby Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure Circulation, October 30, 2001; 104(18): 2177 - 2181. [Abstract] [Full Text] [PDF]

				H. M. Siragy, M. de Gasparo, M. El-Kersh, and R. M. Carey Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP Hypertension, August 1, 2001; 38(2): 183 - 186. [Abstract] [Full Text] [PDF]

				K. Minai, T. Matsumoto, H. Horie, N. Ohira, H. Takashima, H. Yokohama, and M. Kinoshita Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1565 - 1570. [Abstract] [Full Text] [PDF]

				K. G. Lamping and F. M. Faraci Role of Sex Differences and Effects of Endothelial NO Synthase Deficiency in Responses of Carotid Arteries to Serotonin Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 523 - 528. [Abstract] [Full Text] [PDF]

				R. Schulz and G. Heusch Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S136 - S140. [PDF]

				G. Nickenig, A. Stablein, S. Wassmann, C. Wyen, C. Muller, and M. Bohm Acute effects of ACE inhibition on coronary endothelial dysfunction Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 361 - 364. [Abstract] [PDF]

				C. Cheetham, J. Collis, G. O'Driscoll, K. Stanton, R. Taylor, and D. Green Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1461 - 1466. [Abstract] [Full Text] [PDF]

				A. Prasad, S. Husain, W. Schenke, R. Mincemoyer, N. Epstein, and A. A. Quyyumi Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humans J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1467 - 1473. [Abstract] [Full Text] [PDF]

				K. G. Lamping, D. W. Nuno, E. G. Shesely, N. Maeda, and F. M. Faraci Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1906 - H1912. [Abstract] [Full Text] [PDF]

				I. B. Squire, K. P. J. O'Kane, N. Anderson, and J. L. Reid Bradykinin B2 Receptor Antagonism Attenuates Blood Pressure Response to Acute Angiotensin-Converting Enzyme Inhibition in Normal Men Hypertension, July 1, 2000; 36(1): 132 - 136. [Abstract] [Full Text] [PDF]

				E. Aptecar, E. Teiger, P. Dupouy, C. Benvenuti, M. J. Kern, J. Woscoboinik, S. Sediame, J. M. Pernes, A. Castaigne, D. Loisance, et al. Effects of bradykinin on coronary blood flow and vasomotion in transplant patients J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1607 - 1615. [Abstract] [Full Text] [PDF]

				F. M. Faraci and C. D. Sigmund Vascular Biology in Genetically Altered Mice : Smaller Vessels, Bigger Insight Circ. Res., December 3, 1999; 85(12): 1214 - 1225. [Full Text] [PDF]

				P. Pagliaro, H. Senzaki, N. Paolocci, T. Isoda, G. Sunagawa, F. A Recchia, and D. A Kass Specificity of synergistic coronary flow enhancement by adenosine and pulsatile perfusion in the dog J. Physiol., October 1, 1999; 520(1): 271 - 280. [Abstract] [Full Text] [PDF]

				N. Padmanabhan, A. G. Jardine, J. C. McGrath, and J. M. C. Connell Angiotensin-Converting Enzyme–Independent Contraction to Angiotensin I in Human Resistance Arteries Circulation, June 8, 1999; 99(22): 2914 - 2920. [Abstract] [Full Text] [PDF]

				G. O'Driscoll, D. Green, A. Maiorana, K. Stanton, F. Colreavy, and R. Taylor Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1506 - 1511. [Abstract] [Full Text] [PDF]

				H. P. Brunner-La Rocca, G. Vaddadi, and M. D. Esler Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1163 - 1173. [Abstract] [Full Text] [PDF]

				K. G. Lamping, D. W. Nuno, D. A. Chappell, and F. M. Faraci Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1023 - R1029. [Abstract] [Full Text] [PDF]

				A. Prasad, S. Husain, and A. A. Quyyumi Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: A potential role of bradykinin J. Am. Coll. Cardiol., March 1, 1999; 33(3): 796 - 804. [Abstract] [Full Text] [PDF]

				L. S. Zisman Inhibiting Tissue Angiotensin-Converting Enzyme : A Pound of Flesh Without the Blood? Circulation, December 22, 1998; 98(25): 2788 - 2790. [Full Text] [PDF]